vs
Side-by-side financial comparison of CENTRAL PACIFIC FINANCIAL CORP (CPF) and 4D Molecular Therapeutics, Inc. (FDMT). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $72.9M, roughly 1.2× CENTRAL PACIFIC FINANCIAL CORP). CENTRAL PACIFIC FINANCIAL CORP runs the higher net margin — 28.4% vs 22.8%, a 5.6% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 6.0%). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 6.7%).
Central Pacific Bank (CPB) is an American regional commercial bank located throughout the state of Hawaii.
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
CPF vs FDMT — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $72.9M | $85.1M |
| Net Profit | $20.7M | $19.4M |
| Gross Margin | — | — |
| Operating Margin | — | 17.3% |
| Net Margin | 28.4% | 22.8% |
| Revenue YoY | 6.0% | 8508900.0% |
| Net Profit YoY | 16.7% | 139.1% |
| EPS (diluted) | $0.78 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $72.9M | — | ||
| Q4 25 | $76.3M | $85.1M | ||
| Q3 25 | $74.8M | $90.0K | ||
| Q2 25 | $72.8M | $15.0K | ||
| Q1 25 | $68.8M | $14.0K | ||
| Q4 24 | $58.4M | $1.0K | ||
| Q3 24 | $66.6M | $3.0K | ||
| Q2 24 | $64.0M | $5.0K |
| Q1 26 | $20.7M | — | ||
| Q4 25 | $22.9M | $19.4M | ||
| Q3 25 | $18.6M | $-56.9M | ||
| Q2 25 | $18.3M | $-54.7M | ||
| Q1 25 | $17.8M | $-48.0M | ||
| Q4 24 | $11.3M | — | ||
| Q3 24 | $13.3M | $-43.8M | ||
| Q2 24 | $15.8M | $-35.0M |
| Q1 26 | — | — | ||
| Q4 25 | 37.0% | 17.3% | ||
| Q3 25 | 31.6% | -67983.3% | ||
| Q2 25 | 32.8% | -396373.3% | ||
| Q1 25 | 32.8% | -383007.1% | ||
| Q4 24 | 23.0% | — | ||
| Q3 24 | 25.6% | -1704400.0% | ||
| Q2 24 | 32.2% | -849120.0% |
| Q1 26 | 28.4% | — | ||
| Q4 25 | 30.0% | 22.8% | ||
| Q3 25 | 24.8% | -63195.6% | ||
| Q2 25 | 25.1% | -364386.7% | ||
| Q1 25 | 25.8% | -342657.1% | ||
| Q4 24 | 19.4% | — | ||
| Q3 24 | 20.0% | -1461433.3% | ||
| Q2 24 | 24.7% | -699060.0% |
| Q1 26 | $0.78 | — | ||
| Q4 25 | $0.85 | $0.43 | ||
| Q3 25 | $0.69 | $-1.01 | ||
| Q2 25 | $0.67 | $-0.98 | ||
| Q1 25 | $0.65 | $-0.86 | ||
| Q4 24 | $0.42 | — | ||
| Q3 24 | $0.49 | $-0.79 | ||
| Q2 24 | $0.58 | $-0.63 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $402.7M |
| Total DebtLower is stronger | $76.5M | — |
| Stockholders' EquityBook value | $593.9M | $505.7M |
| Total Assets | $7.5B | $566.7M |
| Debt / EquityLower = less leverage | 0.13× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $402.7M | ||
| Q3 25 | — | $305.1M | ||
| Q2 25 | — | $293.2M | ||
| Q1 25 | — | $321.4M | ||
| Q4 24 | — | $424.9M | ||
| Q3 24 | — | $501.9M | ||
| Q2 24 | — | $541.9M |
| Q1 26 | $76.5M | — | ||
| Q4 25 | $76.5M | — | ||
| Q3 25 | $131.5M | — | ||
| Q2 25 | $131.5M | — | ||
| Q1 25 | $131.4M | — | ||
| Q4 24 | $156.3M | — | ||
| Q3 24 | $156.3M | — | ||
| Q2 24 | $156.2M | — |
| Q1 26 | $593.9M | — | ||
| Q4 25 | $592.6M | $505.7M | ||
| Q3 25 | $588.1M | $369.0M | ||
| Q2 25 | $568.9M | $420.9M | ||
| Q1 25 | $557.4M | $469.7M | ||
| Q4 24 | $538.4M | $510.6M | ||
| Q3 24 | $543.7M | $552.9M | ||
| Q2 24 | $518.6M | $588.3M |
| Q1 26 | $7.5B | — | ||
| Q4 25 | $7.4B | $566.7M | ||
| Q3 25 | $7.4B | $424.0M | ||
| Q2 25 | $7.4B | $473.6M | ||
| Q1 25 | $7.4B | $515.7M | ||
| Q4 24 | $7.5B | $560.4M | ||
| Q3 24 | $7.4B | $604.0M | ||
| Q2 24 | $7.4B | $620.1M |
| Q1 26 | 0.13× | — | ||
| Q4 25 | 0.13× | — | ||
| Q3 25 | 0.22× | — | ||
| Q2 25 | 0.23× | — | ||
| Q1 25 | 0.24× | — | ||
| Q4 24 | 0.29× | — | ||
| Q3 24 | 0.29× | — | ||
| Q2 24 | 0.30× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $28.6M |
| Free Cash FlowOCF − Capex | — | $28.5M |
| FCF MarginFCF / Revenue | — | 33.5% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.47× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-109.9M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $97.5M | $28.6M | ||
| Q3 25 | $22.2M | $-46.5M | ||
| Q2 25 | $34.3M | $-43.4M | ||
| Q1 25 | $20.4M | $-47.8M | ||
| Q4 24 | $90.5M | $-134.6M | ||
| Q3 24 | $21.3M | $-29.4M | ||
| Q2 24 | $25.9M | $-30.2M |
| Q1 26 | — | — | ||
| Q4 25 | $92.3M | $28.5M | ||
| Q3 25 | $21.4M | $-46.6M | ||
| Q2 25 | $32.3M | $-43.4M | ||
| Q1 25 | $19.6M | $-48.4M | ||
| Q4 24 | $75.4M | $-138.4M | ||
| Q3 24 | $15.6M | $-31.2M | ||
| Q2 24 | $21.3M | $-30.6M |
| Q1 26 | — | — | ||
| Q4 25 | 121.0% | 33.5% | ||
| Q3 25 | 28.6% | -51765.6% | ||
| Q2 25 | 44.3% | -289620.0% | ||
| Q1 25 | 28.4% | -345635.7% | ||
| Q4 24 | 129.2% | -13837100.0% | ||
| Q3 24 | 23.5% | -1038966.7% | ||
| Q2 24 | 33.2% | -611840.0% |
| Q1 26 | — | — | ||
| Q4 25 | 6.8% | 0.1% | ||
| Q3 25 | 1.2% | 101.1% | ||
| Q2 25 | 2.7% | 440.0% | ||
| Q1 25 | 1.3% | 4507.1% | ||
| Q4 24 | 25.8% | 378600.0% | ||
| Q3 24 | 8.5% | 59266.7% | ||
| Q2 24 | 7.3% | 6980.0% |
| Q1 26 | — | — | ||
| Q4 25 | 4.26× | 1.47× | ||
| Q3 25 | 1.20× | — | ||
| Q2 25 | 1.88× | — | ||
| Q1 25 | 1.15× | — | ||
| Q4 24 | 7.98× | — | ||
| Q3 24 | 1.60× | — | ||
| Q2 24 | 1.64× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
